Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Said Darwazah Insider Profile

4 Followers

Said Darwazah, Chief Executive Officer at Hikma Pharmaceuticals, holds 15.05M shares in Hikma Pharmaceuticals (Ticker: GB:HIK).

Said Darwazah's Trading History

HIKHikma Pharmaceuticals		Jun 02, 2026Chief Executive OfficerUninformative Buy―£247.36M
GB:HIK
Insider Shares: 15.05M (700.43%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 02, 2026Uninformative Buy£0.00111,573£0.00――
Nov 11, 2025Informative Buy£8.37M530,000£1.58K+8.10%―
Jun 03, 2025Uninformative Buy£0.0031,679£0.00――
Mar 04, 2025Uninformative Buy£0.0018,420£0.00――
Mar 13, 2024Uninformative Buy£0.0054,482£0.00――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Said Darwazah insider profile FAQ

What is the percentage of profitable transactions made by Said Darwazah?
The percentage of profitable transactions made by Said Darwazah is 13%.
What is the average return per transaction made by Said Darwazah?
The average return per transaction made by Said Darwazah is -23.70%.
What stocks does Said Darwazah hold?
Said Darwazah holds: GB:HIK stocks.
What was Said Darwazah's most profitable transaction?
Said Darwazah’s most profitable transaction was an Informative Buy of GB:HIK stock on March 13, 2019. The return on the trade was 28.00%.
What is Said Darwazah's role in Hikma Pharmaceuticals?
Said Darwazah's role in Hikma Pharmaceuticals is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.